On the occasion of Dr. John Bartlett stepping down from the HIV treatment guidelines panel, Dr. Paul Sax looks at Dr. Bartlett's remarkable influence on the fields of HIV and infectious disease.

Dr. Paul Sax reviews key recommendations from the recently published primary care guidelines for HIV-infected patients.

Nearly 2 decades after the furor over Lucian Leape's 'Error in Medicine,' the number of hospital deaths related to medical errors continues to grow.

Dr. Paul Sax considers how results of the GARDEL study comparing a 2-drug regimen with a 3-drug regimen might shift the HIV treatment paradigm.

New York State has made it a law that healthcare workers either get a flu shot or wear a mask. It's a good decision, says bioethicist Art Caplan. Patient safety should come first.

FDA Commissioner Margaret Hamburg, MD, talks with Medscape at the National Health Research Forum in Washington, DC.

Dr. Eric Topol talks with Dr. Paul Offit about his new book, which takes on the supplement and alternative medicine industries.

Dr. Paul Sax discusses results of the FLAMINGO study comparing dolutegravir vs ritonavir-boosted darunavir in treatment-naive patients with HIV.

Paul G. Auwaerter, MD, offers his recommendations for the most exciting sessions coming up at ID Week: antibiotic resistance, emerging infections, hep C, MERS virus, and more.

Farzad Mostashari, MD, reflects on his tenure as the National Coordinator for Health Information Technology in an interview with Medscape Editor-in-Chief Eric J. Topol, MD.